Intelligent Bio Solutions Inc.

The momentum for this stock is not very good. Intelligent Bio Solutions Inc. is not a good value stock. Intelligent Bio Solutions Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Intelligent Bio Solutions Inc. .
Log in to see more information.
INBS Fundamental Data by TradingView

News

Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Virtual Conference on September 18-19, 2024
Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Virtual Conference on September 18-19, 2024

Globe Newswire NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a leader in non-invasive drug testing technology, today announced that its...\n more…

What's Going On With Opiate Screening Tests-Focused Intelligent Bio Solutions Stock On Monday?
What's Going On With Opiate Screening Tests-Focused Intelligent Bio Solutions Stock On Monday?

Benzinga Intelligent Bio Solutions stock surges with increased trading volume, driven by progress on its FDA 510(k) submission. The company, specializing in non-invasive testing, advances clinical trials and reports significant growth in drug screening system installations.\n more…

Intelligent Bio Solutions stock rallies on reporting Q4 revenue of $0.73M, up 64% Y/Y
Intelligent Bio Solutions stock rallies on reporting Q4 revenue of $0.73M, up 64% Y/Y

Seeking Alpha - Healthcare Intelligent Bio Solutions stock rallies on reporting Q4 revenue of $0.73M, up 64% Y/Y...\n more…

Intelligent Bio Solutions reports Q4 rvenue $0.73M, up 64% year-over-year
Intelligent Bio Solutions reports Q4 rvenue $0.73M, up 64% year-over-year

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Intelligent Bio Solutions Inc. Announces Preliminary Full Fiscal Year 2024 Revenue Growth of 148% Year-Over-Year
Intelligent Bio Solutions Inc. Announces Preliminary Full Fiscal Year 2024 Revenue Growth of 148% Year-Over-Year

Globe Newswire - 2024 unaudited revenue growth for the fiscal fourth quarter and full year of approximately 64% and 148% year-over-year, respectively - NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Intelligent...\n more…

Intelligent Bio Solutions Advances in FDA Approval Process
Intelligent Bio Solutions Advances in FDA Approval Process

TipRanks Financial Blog Intelligent Bio Solutions ( ($INBS) ) has issued an announcement. Intelligent Bio Solutions Inc. has announced significant progress in its clinical study plan, a cr...\n more…